Larvol Delta - Safety-and-efficacy-of-AMG-820-an-anticolonystimulating-factor-1-receptor-antibody-in-combination-with-pembrolizumab-in-adults-with-advanced-solid-tumors

AMG 820 - Amgen

Keytruda (pembrolizumab) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/33046621

Oct 15, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next